Radiochemistry and Nuclear Imaging Lab
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (3)
2009
-
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET
NeuroImage, Vol. 46, Núm. 2, pp. 447-458
2006
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1 - Pseudoequilibrium interval and quantification methods
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 919-928
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 2 - Ketanserin displacement
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 929-937